An Observational Study of Pediatric Subjects With Globoid Cell Leukodystrophy (GLD)

NCT01093105 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2021-06-03

No results posted yet for this study

Summary

The objective of this study is to evaluate the natural history of disease progression in infants with globoid cell leukodystrophy (GLD).

Conditions

  • Leukodystrophy, Globoid Cell

Sponsors & Collaborators

  • PharmaNet

    collaborator INDUSTRY
  • Nextrials, Inc.

    collaborator INDUSTRY
  • Shire

    lead INDUSTRY

Principal Investigators

  • Study Director · Takeda

Eligibility

Max Age
21 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-04-01
Primary Completion
2012-05-01
Completion
2012-05-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01093105 on ClinicalTrials.gov